Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1686 studies found for:    Open Studies | "Genital Diseases, Female"
Show Display Options
Rank Status Study
21 Recruiting Mechanism of Incontinence Before and After Genital Prolapse Surgery
Condition: Genital Prolapse
Intervention:
22 Unknown  Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Conditions: Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer;   Choriocarcinoma;   Uterine Fibroids;   Endometriosis
Intervention:
23 Not yet recruiting Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: entinostat;   Drug: avelumab;   Drug: Placebo
24 Not yet recruiting Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery
Conditions: Endometritis;   Complication, Postoperative
Interventions: Procedure: Povidone Iodine;   Procedure: Chlorhexidine gluconate
25 Recruiting Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)
Conditions: Uterine Fibroids;   Adenomyosis
Intervention: Device: MRI-HIFU
26 Not yet recruiting Carboplatin-cyclophosphamide Combined With Atezolizumab
Conditions: Breast Cancer;   Cervix Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: carbplatin, cyclophophamide, atezolizumab
27 Not yet recruiting Letrozole in Stimulated IVF Cycles
Condition: Subfertility
Intervention: Drug: Letrozole
28 Not yet recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
29 Not yet recruiting Thyroid Autoimmunity and Reproductive Failure in Danish Women
Conditions: Thyroid;   Infertility;   Autoantibodies;   Autoimmunity;   Pregnancy Loss
Intervention:
30 Recruiting A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Insufficiency Patients
Conditions: Primary Ovarian Insufficiency;   Premature Ovarian Failure;   Infertility
Intervention: Biological: human amniotic epithelial cells (hAECs) transplantation
31 Not yet recruiting LLETZ Under Direct Colposcopic Vision
Condition: Uterine Cervical Dysplasia
Interventions: Device: LLETZ with colposcopy;   Other: LLETZ without colposcopy
32 Not yet recruiting Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Condition: Genital Herpes Simplex Type 2
Intervention: Other: Non-interventional Study
33 Not yet recruiting Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment
Condition: Uterine Cervical Neoplasms
Intervention:
34 Not yet recruiting Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis
Condition: Vulvovaginal Candidiasis
Interventions: Device: LactiSal vaginal gel 1%;   Device: LactiSal vaginal tablet 50mg;   Drug: Clotrimazole vaginal tablet 100mg
35 Not yet recruiting PET (Positron Emission Tomography) Imaging Studies With NIS Reporter
Conditions: Myeloma;   Endometrial Cancer
Intervention: Drug: BF4
36 Not yet recruiting The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis
Conditions: Bacterial Vaginosis;   HIV
Interventions: Drug: Norethisterone enantate;   Device: Condoms
37 Not yet recruiting Early Screening for Chlamydia Trachomatis in Young Women for Primary Prevention of Pelvic Inflammatory Disease
Condition: Genital Chlamydia Trachomatis Infection
Interventions: Other: Testing for Ct infection immediately;   Other: Testing for Ct infection at the end of the study
38 Recruiting Irisin Hormone Levels in Endometrial Hyperplasia
Condition: Endometrial Hyperplasia
Intervention:
39 Not yet recruiting Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Interventions: Drug: Part A: Dose Escalation of Cantrixil;   Drug: Part B: Expansion Cohort of Cantrixil;   Drug: Part C: Twice weekly dosing of Cantrixil
40 Not yet recruiting Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Conditions: Bleeding;   Implants;   Breakthrough Bleeding
Interventions: Drug: Tamoxifen;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years